MktsMarkets

Werewolf Therapeutics, Inc.
NASDAQ: HOWLKey statistics
HOWL News
Stories mentioning HOWL from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 8,181 | 6,933 | 11,634 | 13,143 | 13,120 | 15,727 | 12,528 | 15,271 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 13,271 | 9,418 | 15,726 | 17,542 | 17,991 | 20,348 | 17,124 | 20,103 |
| Operating Income (Loss) | (13,271) | (9,418) | (15,726) | (17,542) | (17,991) | (20,348) | (17,124) | (18,960) |
| Interest Income | 433.00 | 564.00 | 697.00 | 850.00 | 997.00 | 1,309 | 1,598 | 1,793 |
| Interest Expense | ||||||||
| Other Expense | 674.00 | 1,842 | 0.00 | 11.00 | 168.00 | (94.00) | 97.00 | 1,613 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (13,532) | (8,381) | (16,370) | (17,982) | (18,089) | (20,400) | (16,673) | (17,249) |
| Earnings Per Share (Basic) | (0.28) | (0.18) | (0.36) | (0.40) | (0.40) | (0.47) | (0.38) | (0.40) |
| Earnings Per Share (Diluted) | (0.28) | (0.18) | (0.36) | (0.40) | (0.40) | (0.47) | (0.38) | (0.43) |
| Weighted Average Shares Outstanding (Basic) | 48,597 | 46,019 | 45,804 | 44,982 | 44,827 | 43,332 | 43,705 | 43,521 |
| Weighted Average Shares Outstanding (Diluted) | 49,388 | 46,810 | 45,804 | 44,982 | 44,827 | 43,860 | 43,705 | 44,043 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About HOWL
Werewolf Therapeutics, Inc. (NASDAQ: HOWL) is a stock listed on the Nasdaq Stock Market under the ticker symbol HOWL. It last traded at $1.05 (Nov 17, 2026, 4:00 PM ET), up 6.0% on the day. That gives Werewolf Therapeutics a market capitalisation of $51.0M.
Over the past 52 weeks HOWL has traded between $0.2700 and $1.20.
For the quarter ended Mar 31, 2026 it reported a net loss of $13.5M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$13.5M |
| Dec 31, 2025 | — | -$8.4M |
| Sep 30, 2025 | — | -$16.4M |
| Jun 30, 2025 | — | -$18.0M |
From Werewolf Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…